Glomerulonephritis (actually glomerulitis) is an inflammation of the glomeruli (kidney filters, part of the 1.2 million nephrons of each kidney). Chronic glomerulonephritis, which eventually leads to glomerulosclerosis, represents the main cause of dialysis-dependent kidney failure. In autoimmune glomerulonephritis autoantibodies are directed against the basement membrane of the kidney glomeruli (GBM antigens). Anti-GBM glomerulonephritis accounts for 0.5 to 2% of all glomerulonephritides.
Goodpasture's syndrome (pulmonary-renal syndrome) is a special form of autoimmune glomerulonephritis named after the US American pathologist Ernest William Goodpasture (1886-1960), who in 1919 described the combination of glomerulonephritis with pulmonary haemorrhage. This rare syndrome affects men six times more often than women, and predominantly those in young adulthood. It is clinically characterised by the combination of rapid progressive anti-basement membrane glomerulonephritis and pulmonary haemosiderosis, whereby pulmonary haemorrhage often occurs as the first sign.
The primary target antigen of all anti-GBM glomerulonephritides, including the classic Goodpasture's syndrome, is the NC1 region of the alpha-3 chain of the network-structured type IV collagen of the basement membrane lamina densa. These autoantibodies, which can be detected qualitatively or quantitatively in IIFT and quantitatively in the Anti-GBM ELISA, can be directed against the alveolar basement membrane or against the glomerular basement membrane. In cases without lung involvement GBM antibodies are detected in the serum or plasma of over 60% of patients, in cases with lung involvement in over 90%. They are predominantly of class IgG, more rarely of class IgA and IgM. Clinical progression of the disease correlates with antibody concentration. High-titer circulating GBM antibodies indicate an unfavourable progression. With a negative serum result and continuing suspicion of anti-GBM glomerulonephritis, a kidney biopsy should be performed.
Patients with mit Anti-GBM glomerulonephritides are often also ANCA positive (>35%). Positive results can indicate rapid-progressive glomerulonephritis or GPA. Therefore, parallel analysis of ANCA and Anti-GBM antibodies is recommended in patients with ANCA-associated vasculitis (AAV) with renal involvement.
Licda.Rosa Hernandez & Lic. Oscar Sandoval
INSULAB S.A. de C.V
End of calle padres aguilar and 79 av. sur
Clinica Corazon de Maria, Colonia Escalon
Jose Ricardo Acosta
DIPRODI (Distribuidora de Productos Para DiagnosticoS. De R.L. de C.V.)
ph 22307121 Tegucigalpa
Residencial Palza, Bloque 32, Casa No. 1
Ms. Triana Delfin
Circ. Durango 1429 1C
Phone: +598 2 916 8969
vCard Download vCard
Abdulsamad Allengawi / Adil Muneeb
Global Consultancy House (GCH)
Road No. 18, Block No: 321, Exhibition Avenue
Office: 22, Building No: 232, Mohammed Jalal Building
Kingdom of Bahrain
Mr Stephen Harland-Smith
ESL Biosciences (Australia) (2012) Pty
2150 New South Wales
2-4 Giffnock Avenue
PO Box 202 / Macquarie Park Business Hub /North Ryde BC, NSW 1670, Australia Suite 3
Dr. Khalifa Eltayeb Khalafalla
K-BIOanalytica Co. Ltd.
Al -Sayed Abdel Rahman Street / Al Qasr street Junction
Rayan Specialized laboratory Building/ P.O.Box 11656
Khalid Abdalla Abdelrahim AL Fahim
AL Fahim Health Care Solutions LLC
Boulevard Plaza Tower 2, Office 1904
United Arab Emirates